期刊文献+

Regulatory T cells in inflammatory bowel diseases and colorectal cancer 被引量:7

Regulatory T cells in inflammatory bowel diseases and colorectal cancer
下载PDF
导出
摘要 Regulatory T cells(T regs) are key elements in immunological self-tolerance.The number of T regs may alter in both peripheral blood and in colonic mucosa during pathological circumstances.The local cellular,microbiological and cytokine milieu affect immunophenotype and function of T regs.Forkhead box P3+ T regs function shows altered properties in inflammatory bowel diseases(IBDs).This alteration of T regs function can furthermore be observed between Crohn's disease and ulcerative colitis,which may have both clinical and therapeutical consequences.Chronic mucosal inflammation may also influence T regs function,which together with the intestinal bacterial flora seem to have a supporting role in colitis-associated colorectal carcinogenesis.T regs have a crucial role in the immunoevasion of cancer cells in sporadic colorectal cancer.Furthermore,their number and phenotype correlate closely with the clinical outcome of the disease,even if their contribution to carcinogenesis has previously been controversial.Despite knowledge of the clinical relationship between IBD and colitis-associated colon cancer,and the growing number of immunological aspects encompassing sporadic colorectal carcinogenesis,the molecular and cellular links amongst T regs,regulation of the inflammation,and cancer development are still not well understood.In this paper,we aimed to review the current data surrounding the role of T regs in the pathogenesis of IBD,colitis-associated colon cancer and sporadic colorectal cancer. Regulatory T cells (Tregs) are key elements in immuno- logical self-tolerance. The number of Tregs may alter in both peripheral blood and in colonic mucosa during pathological circumstances. The local cellular, micro- biological and cytokine milieu affect immunophenotype and function of Tregs. Forkhead box P3+ Tregs function shows altered properties in inflammatory bowel dis- eases (IBDs). This alteration of Tregs function can fur- thermore be observed between Crohn's disease and ulcerative colitis, which may have both clinical and ther- apeutical consequences. Chronic mucosal inflammation may also influence Tregs function, which together with the intestinal bacterial flora seem to have a support- ing role in colitis-associated colorectal carcinogenesis. Tregs have a crucial role in the immunoevasion of cancer cells in sporadic colorectal cancer. Furthermore, their number and phenotype correlate closely with the clini- cal outcome of the disease, even if their contribution to carcinogenesis has previously been controversial. De- spite knowledge of the clinical relationship between IBD and colitis-associated colon cancer, and the growing number of immunological aspects encompassing spo- radic colorectal carcinogenesis, the molecular and cel-lular links amongst Tregs, regulation of the inflammation, and cancer development are still not well understood. In this paper, we aimed to review the current data sur- rounding the role of Tregs in the pathogenesis of IBD, colitis-associated colon cancer and sporadic colorectal cancer.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第40期5688-5694,共7页 世界胃肠病学杂志(英文版)
关键词 调节性T细胞 肠道疾病 大肠癌 炎症 鸡传染性法氏囊病 溃疡性结肠炎 临床治疗试验 细胞功能 Regulatory T cells Forkhead box P3 Inflam-matory bowel diseases Colitis-associated colon cancer Colorectal cancer
  • 相关文献

参考文献70

  • 1Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med. 2001;193:1303-1310. [PubMed] [DOI].
  • 2Blumberg RS, Strober W. Prospects for research in inflammatory bowel disease. JAMA. 2001;285:643-647. [PubMed] [DOI].
  • 3Wang Y, Liu XP, Zhao ZB, Chen JH, Yu CG. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease. J Dig Dis. 2011;12:286-294. [PubMed] [DOI].
  • 4Erdman SE, Poutahidis T. Roles for inflammation and regulatory T cells in colon cancer. Toxicol Pathol. 2010;38:76-87. [PubMed] [DOI].
  • 5Nishikawa H, Kato T, Tawara I, Takemitsu T, Saito K, Wang L, Ikarashi Y, Wakasugi H, Nakayama T, Taniguchi M. Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. Proc Natl Acad Sci USA. 2005;102:9253-9257. [PubMed] [DOI].
  • 6Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol. 2006;24:209-226. [PubMed] [DOI].
  • 7Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-1061. [PubMed] [DOI].
  • 8Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005;22:329-341. [PubMed] [DOI].
  • 9Loser K, Beissert S. Regulatory T cells: banned cells for decades. J Invest Dermatol. 2012;132:864-871. [PubMed] [DOI].
  • 10Beyer M, Schultze JL. Regulatory T cells in cancer. Blood. 2006;108:804-811. [PubMed] [DOI].

同被引文献69

引证文献7

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部